Sichenzia Ross Ference LLP Represents Aegis Capital Corp. as Sole Bookrunner in $14.4 Million Bought Deal Offering of Avinger, Inc. Common Stock
Press Release – New York, NY – February 2, 2021 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten offering of 10,000,000 shares of the common stock of Avinger, Inc. (NASDAQ: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), at a price of $1.44 per share. The gross proceeds of the offering were approximately $14.4 million, prior to deducting underwriting discounts and commissions and estimated offering expenses.
The shares were offered pursuant to a shelf registration statement previously filed with and declared effective by the SEC.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin M. Ocasio, and Jay Yamamoto, and associate Matthew Siracusa.
- Sichenzia Ross Ference LLP Represents High Tide Inc. in the $20.64 million acquisition of Fab Nutrition, LLC - May 11, 2021
- Sichenzia Ross Ference LLP Represents Aegis Capital in $48.3 Million Underwritten Public Offering of Farmmi, Inc. - May 3, 2021
- Sichenzia Ross Ference LLP Wins Appeal Before the Second Circuit in a Lawsuit Brought By Investors in Connection with a Private Placement - April 30, 2021